CeylonBiomedical_Logo_50_whiteCeylonBiomedical_Logo_50CeylonBiomedical_Logo_50CeylonBiomedical_Logo_50
  • Home
  • What We Do
  • About Us
  • Media
  • Contact
✕

News

The latest news from Ceylon Biomedical.

Post Types

Sample press release number one

2025-06-11
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris condimentum libero et odio aliquet, nec tempor purus pretium. Mauris in neque ut orci finibus suscipit. Donec velit felis, ultrices id dapibus ac, efficitur sed diam. Suspendisse blandit ex risus, eu tempus tortor blandit id. Duis volutpat pellentesque imperdiet. Proin porttitor, […]
Read More
Previous

Ceylon Biomedical is focused on the development and manufacture of clinically relevant, chemotype-defined cannabis-based therapeutics. With deep scientific expertise and strict adherence to EU-GMP standards, we produce high-purity APIs and finished dosage forms designed for safety, consistency, and therapeutic efficacy. Our work supports the advancement of evidence-based cannabis medicine, with a global reach across regulated markets in Europe, Asia, and the Americas.

Navigation

  • Home
  • What We Do
  • About Us
  • Media
  • Contact

Get in touch

Reach out to explore how we can support your clinical or commercial product development needs.

Contact Us
© 2025 Ceylon Biomedical | All Rights Reserved